...ELNs). LC-MS identified compounds enriched in CJ (n=3) and CJ-ELNs (n=3), and then compounds specifically enriched in CJ...
...ELN) 2022 risk category. These results were confirmed both in an internal and external validation cohort. Allogeneic hem...
...ELN) risk stratification guidelines. Archival patients' samples (N=48) from the Fred Hutchinson Cancer Center Leukemia B...
...ELNs Additionally, the modification of ELNs and loading bioactive compounds in ELNs for improved effects on IBD are disc...
...ELN intermediate-adverse karyotype(OR=1.33, P = 0.045), DNMT3A mutation (OR=1.32, P = 0.047) and IDH1/2 mutation (OR=1.9...
...ELNs retrieved in CC patients undergoing hemicolectomy and to explore the potential for establishing a minimum ELNs thre...
...ELN 2020 criteria, without ABL mutations) were matched 1:4 to 124 TKI-sensitive controls on age, sex, Sokal score, and b...
...ELN. Truncating variants in exons 1-29 typically produce non-syndromic SVAS through elastin haploinsufficiency, whereas ...
...Eln; Ctgf; Acta2; Plod2; Hpse) significantly increased with androgen (72 h), as did TGF-β signalling (Tgfb1; Tgfb3). We ...
...ELN favorable-risk, treated with oral azacitidine maintenance following intensive induction-consolidation. MRD was asses...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269